Metropolitan Life Insurance Company (MetLife)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,040
| Closed | -$1.74M | – | 2685 |
|
|
2021
Q4 | $1.74M | Sell |
8,040
-142
| -2% | -$27.9K | 0.02% | 613 |
|
|
2021
Q3 | $1.51M | Sell |
8,182
-8,720
| -52% | -$1.72M | 0.02% | 674 |
|
|
2021
Q2 | $3.03M | Buy |
16,902
+8,501
| +101% | +$1.62M | 0.02% | 678 |
|
|
2021
Q1 | $1.41M | Buy |
8,401
+452
| +6% | +$75.4K | 0.02% | 735 |
|
|
2020
Q4 | $1.21M | Sell |
7,949
-207
| -3% | -$27.2K | 0.02% | 764 |
|
|
2020
Q3 | $824K | Sell |
8,156
-365
| -4% | -$40K | 0.01% | 861 |
|
|
2020
Q2 | $1.03M | Sell |
8,521
-3,148
| -27% | -$354K | 0.02% | 724 |
|
|
2020
Q1 | $1.11M | Sell |
11,669
-634
| -5% | -$60.3K | 0.02% | 627 |
|
|
2019
Q4 | $1.08M | Buy |
12,303
+82
| +0.7% | +$7.21K | 0.02% | 848 |
|
|
2019
Q3 | $975K | Sell |
12,221
-283
| -2% | -$22.8K | 0.02% | 869 |
|
|
2019
Q2 | $976K | Buy |
12,504
+26
| +0.2% | +$2.43K | 0.02% | 911 |
|
|
2019
Q1 | $1.46M | Buy |
12,478
+16
| +0.1% | +$1.86K | 0.03% | 659 |
|
|
2018
Q4 | $1.36M | Buy |
12,462
+45
| +0.4% | +$5.22K | 0.03% | 628 |
|
|
2018
Q3 | $1.59M | Sell |
12,417
-125
| -1% | -$15.5K | 0.03% | 651 |
|
|
2018
Q2 | $1.42M | Buy |
12,542
+72
| +0.6% | +$7.91K | 0.02% | 736 |
|
|
2018
Q1 | $1.4M | Buy |
12,470
+99
| +0.8% | +$12.6K | 0.02% | 734 |
|
|
2017
Q4 | $1.83M | Sell |
12,371
-28,485
| -70% | -$3.62M | 0.02% | 599 |
|
|
2017
Q3 | $4.79M | Sell |
40,856
-1,542
| -4% | -$197K | 0.03% | 605 |
|
|
2017
Q2 | $5.5M | Buy |
42,398
+29
| +0.1% | +$3.62K | 0.04% | 516 |
|
|
2017
Q1 | $5.74M | Buy |
42,369
+2,199
| +5% | +$333K | 0.04% | 500 |
|
|
2016
Q4 | $5.76M | Sell |
40,170
-1,139
| -3% | -$145K | 0.04% | 483 |
|
|
2016
Q3 | $4.88M | Sell |
41,309
-1,149
| -3% | -$138K | 0.04% | 548 |
|
|
2016
Q2 | $4.5M | Sell |
42,458
-789
| -2% | -$88K | 0.03% | 578 |
|
|
2016
Q1 | $4.82M | Buy |
43,247
+927
| +2% | +$117K | 0.04% | 537 |
|
|
2015
Q4 | $6.63M | Buy |
42,320
+334
| +0.8% | +$48.6K | 0.05% | 357 |
|
|
2015
Q3 | $5.51M | Sell |
41,986
-933
| -2% | -$150K | 0.04% | 456 |
|
|
2015
Q2 | $7.47M | Buy |
+42,919
| New | +$7.72M | 0.05% | 357 |
|
|
2015
Q1 | – | Sell |
-42,375
| Closed | -$5.49M | – | 2442 |
|
|
2014
Q4 | $5.49M | Buy |
42,375
+636
| +2% | +$82K | 0.04% | 497 |
|
|
2014
Q3 | $5.37M | Buy |
41,739
+2,777
| +7% | +$286K | 0.04% | 466 |
|
|
2014
Q2 | $3.45M | Sell |
38,962
-1,678
| -4% | -$161K | 0.02% | 733 |
|
|
2014
Q1 | $3.82M | Buy |
40,640
+917
| +2% | +$93.8K | 0.03% | 666 |
|
|
2013
Q4 | $4.49M | Buy |
39,723
+374
| +1% | +$33.7K | 0.03% | 568 |
|
|
2013
Q3 | $3.1M | Buy |
39,349
+213
| +0.5% | +$15.6K | 0.02% | 711 |
|
|
2013
Q2 | $2.58M | Buy |
+39,136
| New | +$2.52M | 0.02% | 746 |
|
Other funds holding UTHR
ACA
APM
Metropolitan Life Insurance Company (MetLife)'s UTHR Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 8,040 shares — an estimated $1.74M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in UTHR in Q2 2013 and held it in 34 quarters. The position peaked at $7.47M in Q2 2015. 428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 8,040 United Therapeutics shares in Q1 2022, an estimated $1.74M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in United Therapeutics in Q2 2013 and held it in 34 quarters.
- Metropolitan Life Insurance Company (MetLife)'s United Therapeutics position peaked at $7.47M in Q2 2015.
- 428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.